Rictor gene amplification 13-16 and Rictor protein overexpression 10, 17-21 have been found in various cancer types and correlated with tumor progression and metastasis, highlighting the potential therapeutic advantage for targeting Rictor. Here, RICTOR is linked to neoplasm.